254 related articles for article (PubMed ID: 29939868)
1. Screening of hepatitis C virus infection in adult general population in Spain.
Gómez-Escolar Viejo L; García Herola A; Sáez Lloret I; Sánchez Ruano F; Clemente Paulino I; Quílez Ivorra C; Almenta Saavedra I; Martínez Pérez D; Valverde de la Osa J
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1077-1081. PubMed ID: 29939868
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C seroprevalence in an at-risk population in the southwest Madrid region of Spain.
Alonso López S; Agudo Fernández S; García Del Val A; Martínez Abad M; López Hermosa Seseña P; Izquierdo MJ; Núñez I; Berbel León S; Visedo Campillo L; Guisado Pérez C; Sánchez Lozano S; Mariño Pfeiffer I; García Bermúdez L; Sánchez Jiménez FJ; López Vega E; Zambrano Álvarez J; Castro Pastor ML; Montes Ramírez G; Murillo C; Villafranca Ortega N; Ayuso Hernández I; Espejo M; Lasala López P; Rodríguez Caravaca G; Carrascosa Aguilar B; Gutiérrez García ML; Fernández Rodríguez C
Gastroenterol Hepatol; 2016 Dec; 39(10):656-662. PubMed ID: 27417563
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
Benouda A; Boujdiya Z; Ahid S; Abouqal R; Adnaoui M
Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
[TBL] [Abstract][Full Text] [Related]
4. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
[TBL] [Abstract][Full Text] [Related]
5. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.
Kileng H; Gutteberg T; Goll R; Paulssen EJ
BMC Infect Dis; 2019 Feb; 19(1):189. PubMed ID: 30808290
[TBL] [Abstract][Full Text] [Related]
6. A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.
Carvalho-Gomes Â; Cubells A; Pallarés C; Hontangas V; Conde I; Di Maira T; Peiró S; Sanfélix-Gimeno G; López-Labrador FX; Berenguer M
PLoS One; 2020; 15(2):e0228351. PubMed ID: 32045417
[TBL] [Abstract][Full Text] [Related]
7. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
8. Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
Hossain N; Puchakayala B; Kanwar P; Verma S; Abraham G; Ivanov Z; Niaz MO; Mohanty SR
Dig Dis Sci; 2017 Nov; 62(11):3193-3199. PubMed ID: 28913613
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of diagnosed and undiagnosed hepatitis C virus infection in Navarra, Spain, 2014-2016.
Aguinaga A; Díaz-González J; Pérez-García A; Barrado L; Martínez-Baz I; Casado I; Juanbeltz R; Ezpeleta C; Castilla J
Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(6):325-331. PubMed ID: 28110858
[TBL] [Abstract][Full Text] [Related]
10. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.
Ragan K; Pandya A; Holotnak T; Koger K; Collins N; Swain MG
Can J Gastroenterol Hepatol; 2020; 2020():5258289. PubMed ID: 32211349
[TBL] [Abstract][Full Text] [Related]
12. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy.
Popovici O; Molnar GB; Popovici F; Janţă D; Pistol A; Azoicăi D
J Gastrointestin Liver Dis; 2016 Mar; 25(1):25-32. PubMed ID: 27014751
[TBL] [Abstract][Full Text] [Related]
13. A nationwide seroepidemiology of hepatitis C virus infection in South Korea.
Kim DY; Kim IH; Jeong SH; Cho YK; Lee JH; Jin YJ; Lee D; Suh DJ; Han KH; Park NH; Kang HY; Jung YK; Kim YS; Kim KA; Lee YJ; Lee BS; Yim HJ; Lee HJ; Baik SK; Tak WY; Lee SJ; Chung WJ; Choi SK; Cho EY; Heo J; Kim DJ; Song BC; Kim MW; Lee J; Chae HB; Choi DH; Choi HY; Ki M
Liver Int; 2013 Apr; 33(4):586-94. PubMed ID: 23356674
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department.
Lyons MS; Kunnathur VA; Rouster SD; Hart KW; Sperling MI; Fichtenbaum CJ; Sherman KE
Clin Infect Dis; 2016 May; 62(9):1066-71. PubMed ID: 26908799
[TBL] [Abstract][Full Text] [Related]
16. Community-based screening of hepatitis C with a one-step RNA detection algorithm from dried-blood spots: Analysis of key populations in Barcelona, Spain.
Saludes V; Folch C; Morales-Carmona A; Ferrer L; Fernàndez-López L; Muñoz R; Jiménez M; Loureiro E; Fernández-Dávila P; Bascuñana E; Casabona J; Martró E
J Viral Hepat; 2018 Mar; 25(3):236-244. PubMed ID: 29053912
[TBL] [Abstract][Full Text] [Related]
17. Acceptance, yield and feasibility of attaching HCV birth cohort screening to colorectal cancer screening in Spain.
García-Alonso FJ; Bonillo-Cambrodón D; Bermejo A; García-Martínez J; Hernández-Tejero M; Valer López Fando P; Piqueras B; Bermejo F
Dig Liver Dis; 2016 Oct; 48(10):1237-42. PubMed ID: 27481585
[TBL] [Abstract][Full Text] [Related]
18. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?
Merza MA; Haji SM; Alsharafani AM; Muhammed SU
Int J Mycobacteriol; 2016 Sep; 5(3):313-317. PubMed ID: 27847016
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain].
Cifuentes C; Mira JA; Vargas J; Neukam K; Escassi C; García-Rey S; Gilabert I; González-Monclova M; Bernal S; Pineda JA
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):452-7. PubMed ID: 22541340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
